TCAR vs. TF-CAS
The objective of this study was to compare outcomes associated with Transcarotid Artery Revascularization and transfemoral carotid artery stenting using data from the VQI-TSP.
“Among patients undergoing treatment for carotid stenosis, transcarotid artery revascularization, compared with transfemoral carotid artery stenting, was significantly associated with a lower risk of stroke or death.”
JAMA. 2019 Dec 17;322(23):2313-2322
TCAR Vs. TF-CAS Results*
The investigators found a significant decrease in stroke and death for patients who underwent TCAR as well as procedural efficiencies such as less radiation and less contrast. The investigators also found a significant decrease in stroke or death at one year.
*Study n=3,286
Related publications
Association of TCAR vs TF-CAS With Stroke or Death Among Patients With Carotid Artery Stenosis
Marc L. Schermerhorn et al
Learning Curve for Surgeons Adopting TCAR Based on the Vascular Quality Initiative...
Vikram S. Kashyap et al
In-hospital Outcomes of TCAR and CEA in the Society for Vascular Surgery VQI
Marc L. Schermerhorn et al
TCAR vs. transfemoral carotid artery stenting in the Society for Vascular Surgery VQI
Mahmoud B. Malas et al
Discover more clinical studies
First in man results using ENROUTE® Transcarotid Neuroprotection System.
Pre-Market Approval of the ENROUTE Neuroprotection System.
Post Approval registry validating safety and efficacy of the ENROUTE Stent.
Real world population data validating CEA-like outcomes.
